SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ju Sun Song, Eun-Suk Kang, Eun Yeon Joo, Seung Bong Hong, Dae-Won Seo, Soo-Youn Lee, Absence ofHLA-B*1502andHLA-A*3101Alleles in 9 Korean Patients With Antiepileptic Drug-Induced Skin Rash: A Preliminary Study, Annals of Laboratory Medicine, 2014, 34, 5, 372

    CrossRef

  2. 2
    P W Payne, Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?, The Pharmacogenomics Journal, 2014, 14, 5, 473

    CrossRef

  3. 3
    Francesco Pappalardo, Darren Flower, Giulia Russo, Marzio Pennisi, Santo Motta, Computational modelling approaches to vaccinology, Pharmacological Research, 2014,

    CrossRef

  4. 4
    Jessica Whritenour, Susan Cole, Xu Zhu, Dingzhou Li, Thomas T. Kawabata, Development and partial validation of a mouse model for predicting drug hypersensitivity reactions, Journal of Immunotoxicology, 2014, 11, 2, 141

    CrossRef

  5. 5
    Vincent Descamps, Sylvie Ranger-Rogez, DRESS syndrome, Revue du Rhumatisme, 2014, 81, 1, 16

    CrossRef

  6. 6
    Vincent Descamps, Sylvie Ranger-Rogez, DRESS syndrome, Joint Bone Spine, 2014, 81, 1, 15

    CrossRef

  7. 7
    Agnès Samain, Anne-Bénédicte Duval-Modeste, Pascal Joly, Céline Leblanc, Nathalie Massy, Philippe Courville, Odile Goria, Ghassan Riachi, First case of drug rash eosinophilia and systemic symptoms due to boceprevir, Journal of Hepatology, 2014, 60, 4, 891

    CrossRef

  8. 8
    Ingrid Fricke-Galindo, Iris E Martínez-Juárez, Nancy Monroy-Jaramillo, Helgi Jung-Cook, Ramcés Falfán-Valencia, Alberto Ortega-Vázquez, María Elisa Alonso-Vilatela, Marisol López-López, HLA-A*02:01:01/-B*35:01:01/-C*04:01:01haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients, Pharmacogenomics, 2014, 15, 15, 1881

    CrossRef

  9. 9
    David M Haas, Pharmacogenetics and individualizing drug treatment during pregnancy, Pharmacogenomics, 2014, 15, 1, 69

    CrossRef

  10. 10
    Takeo Saito, Kenji Kondo, Yoshimi Iwayama, Ayu Shimasaki, Branko Aleksic, Kazuo Yamada, Tomoko Toyota, Eiji Hattori, Kosei Esaki, Hiroshi Ujike, Toshiya Inada, Hiroshi Kunugi, Tadafumi Kato, Takeo Yoshikawa, Norio Ozaki, Masashi Ikeda, Nakao Iwata, Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population: Support for association of MHC region with psychosis, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2014, 165, 5
  11. 11
    Hiroyuki Niihara, Kunie Kohno, Takeshi Taketani, Sakae Kaneko, Takafumi Ito, Takashi Sugamori, Nobuyuki Takahashi, Tuyoshi Miyaoka, Shihoh Okazaki, Hideaki Yasuda, Motohide Furuya, Michiharu Nagahama, Eishin Morita, Simple and rapid detection of HLA-A*31:01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method, Journal of Dermatological Science, 2014, 74, 1, 88

    CrossRef

  12. 12
    Descamps Vincent, Mikoko Tohyama, Yoko Kano, Tetsuo Shiohara, Human Herpesviruses HHV-6A, HHV-6B & HHV-7, 2014,

    CrossRef

  13. 13
    Bengu Gerceker Turk, Asli Gunaydin, Ilgen Ertam, Gunseli Ozturk, Adverse cutaneous drug reactions among hospitalized patients: five year surveillance, Cutaneous and Ocular Toxicology, 2013, 32, 1, 41

    CrossRef

  14. 14
    Chan-Wei Pan, Chi-Hua Yu, Ding-Lieh Liao, Carbamazepine-induced hypersensitivity syndrome in chronic schizophrenia, General Hospital Psychiatry, 2013, 35, 5, 575.e9

    CrossRef

  15. 15
    Lateef Mohiuddin Khan, Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay – a systematic review, European Journal of Clinical Pharmacology, 2013, 69, 12, 1985

    CrossRef

  16. 16
    J. Kwok, K.M. Kwong, Detection of HLA-B*58:01, the susceptible allele for allopurinol-induced hypersensitivity, by loop-mediated isothermal amplification, British Journal of Dermatology, 2013, 168, 3
  17. 17
    Kazuki UCHIYAMA, Fumika KUBOTA, Noritaka ARIYOSHI, Jun MATSUMOTO, Itsuko ISHII, Mitsukazu KITADA, Development of a Simple Method for Detection of the HLA-A*31:01 Allele, Drug Metabolism and Pharmacokinetics, 2013, 28, 5, 435

    CrossRef

  18. 18
    Zain Husain, Bobby Y. Reddy, Robert A. Schwartz, DRESS syndrome, Journal of the American Academy of Dermatology, 2013, 68, 5, 693.e1

    CrossRef

  19. 19
    Francisco Gallo Puelles, Alejandro Muñoz Jiménez, M. Luisa Velloso Feijoó, Mario Leon Garcia, Sergio Rodriguez Montero, José Luis Marenco de la Fuente, Fever and Exanthema in a Young Patient: Drug Reaction With Eosinophilia and Systemic Symptoms due to Allopurinol, Reumatología Clínica (English Edition), 2013, 9, 6, 379

    CrossRef

  20. 20
    Francisco Gallo Puelles, Alejandro Muñoz Jiménez, M. Luisa Velloso Feijoó, Mario Leon Garcia, Sergio Rodriguez Montero, José Luis Marenco de la Fuente, Fiebre y exantema en un paciente joven: reacción a medicamentos con eosinofilia y síntomas sistémicos al alopurinol, Reumatología Clínica, 2013, 9, 6, 379

    CrossRef

  21. 21
    Michihiro Kamijima, Hailan Wang, Osamu Yamanoshita, Yuki Ito, Lihua Xia, Yukie Yanagiba, Cishan Chen, Ai Okamura, Zhenlie Huang, Xinxiang Qiu, Xiangrong Song, Tingfeng Cai, Lili Liu, Yichen Ge, Yingyu Deng, Hisao Naito, Tetsushi Yoshikawa, Mikiko Tohyama, Laiyu Li, Hanlin Huang, Tamie Nakajima, Occupational trichloroethylene hypersensitivity syndrome: Human herpesvirus 6 reactivation and rash phenotypes, Journal of Dermatological Science, 2013, 72, 3, 218

    CrossRef

  22. 22
    Karmen Stankov, Ana Sabo, Momir Mikov, Pharmacogenetic Biomarkers as Tools for Pharmacoepidemiology of Severe Adverse Drug Reactions, Drug Development Research, 2013, 74, 1
  23. 23
    May P. S. Lam, Chi K. Yeung, Bernard M. Y. Cheung, Pharmacogenetics of Allopurinol—Making an Old Drug Safer, The Journal of Clinical Pharmacology, 2013, 53, 7
  24. 24
    Ronald J. Trent, Pak Leng Cheong, Eng Wee Chua, Martin A. Kennedy, Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care, Pathology, 2013, 45, 4, 357

    CrossRef

  25. 25
    Crispian Scully, Oral and Maxillofacial Medicine, 2013,

    CrossRef

  26. 26
    David M. Haas, David A. Flockhart, Clinical Pharmacology During Pregnancy, 2013,

    CrossRef

  27. 27
    Kelly L. Diegel, Dimitry M. Danilenko, Zbigniew W. Wojcinski, Haschek and Rousseaux's Handbook of Toxicologic Pathology, 2013,

    CrossRef

  28. 28
    Sandra R Knowles, Norman Dewhurst, Neil H Shear, Anticonvulsant hypersensitivity syndrome: an update, Expert Opinion on Drug Safety, 2012, 11, 5, 767

    CrossRef

  29. 29
    Keiko MAEKAWA, Jun NISHIKAWA, Nahoko KANIWA, Emiko SUGIYAMA, Tomoko KOIZUMI, Kouichi KUROSE, Masahiro TOHKIN, Yoshiro SAITO, Development of a Rapid and Inexpensive Assay for Detecting a Surrogate Genetic Polymorphism of HLA-B*58:01: A Partially Predictive but Useful Biomarker for Allopurinol-related Stevens-Johnson Syndrome/toxic Epidermal Necrolysis in Japanese, Drug Metabolism and Pharmacokinetics, 2012, 27, 4, 447

    CrossRef

  30. 30
    Michel Baulac, Martin J Brodie, Anna Patten, Joanna Segieth, Luigi Giorgi, Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial, The Lancet Neurology, 2012, 11, 7, 579

    CrossRef

  31. 31
    Hua Zhong, Ziyuan Zhou, Huan Wang, Jun Niu, WenChieh Chen, Zhiqiang Song, Fei Hao, Prevalence of Cutaneous Adverse Drug Reactions in Southwest China, Dermatitis, 2012, 23, 2, 81

    CrossRef

  32. 32
    Margarida Gonçalo, Derk P. Bruynzeel, Dermatotoxicology, 2012,

    CrossRef

  33. 33
    Sandra R. Knowles, Neil H. Shear, Exanthematic Reactions,
  34. 34
    Managing IADRs – a Risk–Benefit Analysis,